# Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

> **NCT03868020** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Squamous Cell Carcinoma in Cervical Lymph Node

## Interventions

- **PROCEDURE:** Computed Tomography
- **RADIATION:** Fluciclovine F18
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03868020
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-24
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868020, "Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03868020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*